Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.4581 | 79 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.47003 | 78 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.77384 | 81 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.44297 | 77 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.78756 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.78518 | 74 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.25489 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.63626 | 80 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.21677 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.36197 | 78 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.33322 | 78 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.16825 | 76 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.38404 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.31972 | 78 |